Abstract
Intracranial masses may be life-threatening lesions that are refractory to even the most aggressive treatment or benign and require only occasional observation. Metastatic tumors are the most common intracranial tumors in adults, and usually portend a poor prognosis. Glial tumors may be divided into glioblastoma multiforme and other high-grade tumors which progress despite multimodal treatment and low-grade tumors which may be relatively benign. Meningiomas are most often benign tumors that come to clinical attention by causing mass effect or are noticed incidentally on a neuroimaging study ordered for an unrelated reason. Primary central nervous system lymphoma (PCNSL) may occur in both immunocompromised and immunocompetent patients. Important non-neoplastic supratentorial mass lesions include arteriovenous malformations, abscesses, and tumefactive multiple sclerosis. Sellar region tumors may produce headaches, visual field defects, and extraocular movement disorders. The most common lesions in the sellar region are adenomas, craniopharyngiomas, and meningiomas. Cerebellopontine angle lesions such as vestibular schwannomas may come to clinical attention by producing hearing loss or imbalance. Masses that occur with greater frequency in immunocompromised patients, particularly those with HIV include PCNSL and toxoplasmosis. Patients from the tropics and the developing world are at risk for several infections that may produce cerebral masses, most importantly neurocysticercosis and tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bernstein M, Berger M. Neuro-oncology: the essentials. 2nd ed. New York: Thieme; 2008.
Bonneville F, Sarrazin JL, Marsot-Dupuch K, et al. Unusual lesions of the cerebellopontine angle: a segmental approach. Radiographics. 2001;21:419–38.
Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453–61.
Butteriss DJA, Ismail A, Ellison DW, Birchall D. Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol. 2003;76:662–5.
Carpio A, Kelvin EA, Bagiella E, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79:1050–5.
Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45:741–4.
Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999;28:81–117.
Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology. 1992;34:150–4.
Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.
Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76:S20–7.
Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79:1487–95.
Mavrakis AN, Halpern EF, Barker FG, Gonzalez RG, Henson JW. Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology. 2005;65:908–11.
Norden AD, Young GS, Setayesh K, et al. Bevacizumab for recurrent malignant gliomas. Efficacy, toxicity, and patterns of recurrence. Neurology. 2008;70:779–87.
Ogilvy CS, Stieg PE, Awad I, et al. Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32:1458–71.
Serhal D, Weil RJ, Hamrahian AH. Evaluation and management of pituitary incidentalomas. Cleve Clin J Med. 2008;75:793–801.
Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65:476–83.
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66.
Wasay M, Kheleani BA, Moolani MK, et al. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging. 2003;13:240–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tarulli, A. (2016). Intracranial Mass Lesions. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-29632-6_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29630-2
Online ISBN: 978-3-319-29632-6
eBook Packages: MedicineMedicine (R0)